[Effect of electroacupuncture combined with Ginkgo biloba extract (GBE 50) on learning-memory ability and hippocampal cytokine levels in rats with dysmnesy]. 2009

Rong Shen, and Ying Xu, and Zhi-Xiong Zhang, and Yun Li, and Xing-Yu Wang
The Affiliated Renji Hospital of Shanghai Jiaotong University, Shanghai 200001, China.

OBJECTIVE To observe the effect of electroacupuncture (EA) combined with Ginkgo biloba extract (GBE 50) on learning-memory ability and hippocampal cytokine contents in aging rats for exploring its underlying mechanism in the treatment of dysmnesy. METHODS Forty-five SD rats were randomly divided into control (n=9), model (n=8), EA (n=10), GBE 50 (n=9) and EA + GBE 50 (n=9) groups. The dysmnesy model was established by D-galactose intraperitoneal injection for 42 days. EA (3 Hz, 1 mA) was applied to "Baihui" (GV 20) and "Zusanli" (ST 36) for 20 min, once every other day for 21 days. The learning-memory ability was detected by Morris water maze tests. The levels of IL-1beta, IL-6 and TNF-alpha in hippocampus were examined by radioimmunoassay. RESULTS Compared with control group, the mean escape latency (MEL) of the rats in model group was significantly greater on the 2nd and 3rd day training (P<0.05, P<0.01), and the percent of swimming distance (PSD) in the target quadrant was shortened significantly (P<0.01). Compared with model group, the MEL values of the rats in EA, GBE 50 and EA + GBE 50 groups were significantly shortened (P<0.05, P<0.01), and the PSD values of the later 3 groups increased considerably (P<0.01). Comparison among the EA, GBE 50 and EA + GBE 50 groups showed that the MEL of EA + GBE 50 was obviously shorter than those of EA and GBE 50 groups (P<0.05). Compared with control group, the contents of IL-1beta) and TNF-alpha in hippocampus in model group increased significantly, but IL-6 decreased markedly (P<0.05, P<0.01). In comparison with model group, the IL-1beta contents of EA, GBE 50 and EA + GBE 50 groups, and TNF-alpha of EA and EA + GBE 50 groups were reduced significantly (P<0.05, P<0.01); and the contents of IL-6 in GBE 50 and EA + GBE 50 groups increased apparently (P<0.01). No significant differences were found between model and EA groups in IL-6 levels, and between model and EA + GBE 50 groups in hippocampal TNF-a levels (P>0.05). CONCLUSIONS Both EA and GBE 50 can improve the dysmnesy rats' learning-memory ability, which may be closely associated with their effects in regulating hippocampal IL-1beta, IL-6 and TNF-alpha levels to relieve the inflammatory reaction. Combined administration of EA and GBE 50 has a synergic effect.

UI MeSH Term Description Entries
D008297 Male Males
D008568 Memory Complex mental function having four distinct phases: (1) memorizing or learning, (2) retention, (3) recall, and (4) recognition. Clinically, it is usually subdivided into immediate, recent, and remote memory.
D008569 Memory Disorders Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions. Memory Loss,Age-Related Memory Disorders,Memory Deficits,Memory Disorder, Semantic,Memory Disorder, Spatial,Memory Disorders, Age-Related,Retention Disorders, Cognitive,Semantic Memory Disorder,Spatial Memory Disorder,Age Related Memory Disorders,Age-Related Memory Disorder,Cognitive Retention Disorder,Cognitive Retention Disorders,Deficit, Memory,Deficits, Memory,Memory Deficit,Memory Disorder,Memory Disorder, Age-Related,Memory Disorders, Age Related,Memory Disorders, Semantic,Memory Disorders, Spatial,Memory Losses,Retention Disorder, Cognitive,Semantic Memory Disorders,Spatial Memory Disorders
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006624 Hippocampus A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation. Ammon Horn,Cornu Ammonis,Hippocampal Formation,Subiculum,Ammon's Horn,Hippocampus Proper,Ammons Horn,Formation, Hippocampal,Formations, Hippocampal,Hippocampal Formations,Hippocampus Propers,Horn, Ammon,Horn, Ammon's,Proper, Hippocampus,Propers, Hippocampus,Subiculums
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Rong Shen, and Ying Xu, and Zhi-Xiong Zhang, and Yun Li, and Xing-Yu Wang
January 2003, In vivo (Athens, Greece),
Rong Shen, and Ying Xu, and Zhi-Xiong Zhang, and Yun Li, and Xing-Yu Wang
February 2012, Phytotherapy research : PTR,
Rong Shen, and Ying Xu, and Zhi-Xiong Zhang, and Yun Li, and Xing-Yu Wang
July 2012, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
Rong Shen, and Ying Xu, and Zhi-Xiong Zhang, and Yun Li, and Xing-Yu Wang
July 1999, Nihon Jibiinkoka Gakkai kaiho,
Rong Shen, and Ying Xu, and Zhi-Xiong Zhang, and Yun Li, and Xing-Yu Wang
September 2012, Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology,
Rong Shen, and Ying Xu, and Zhi-Xiong Zhang, and Yun Li, and Xing-Yu Wang
April 2014, Zhen ci yan jiu = Acupuncture research,
Rong Shen, and Ying Xu, and Zhi-Xiong Zhang, and Yun Li, and Xing-Yu Wang
January 2017, Frontiers in pharmacology,
Rong Shen, and Ying Xu, and Zhi-Xiong Zhang, and Yun Li, and Xing-Yu Wang
March 2006, Chinese journal of integrative medicine,
Rong Shen, and Ying Xu, and Zhi-Xiong Zhang, and Yun Li, and Xing-Yu Wang
November 2011, Molecules (Basel, Switzerland),
Rong Shen, and Ying Xu, and Zhi-Xiong Zhang, and Yun Li, and Xing-Yu Wang
January 1991, Pharmacology, biochemistry, and behavior,
Copied contents to your clipboard!